1. Home
  2. CVKD vs STAI Comparison

CVKD vs STAI Comparison

Compare CVKD & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • STAI
  • Stock Information
  • Founded
  • CVKD 2022
  • STAI 2011
  • Country
  • CVKD United States
  • STAI United States
  • Employees
  • CVKD N/A
  • STAI N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • STAI
  • Sector
  • CVKD Health Care
  • STAI
  • Exchange
  • CVKD Nasdaq
  • STAI Nasdaq
  • Market Cap
  • CVKD 29.5M
  • STAI 16.6M
  • IPO Year
  • CVKD 2023
  • STAI N/A
  • Fundamental
  • Price
  • CVKD $12.71
  • STAI $0.68
  • Analyst Decision
  • CVKD Strong Buy
  • STAI
  • Analyst Count
  • CVKD 1
  • STAI 0
  • Target Price
  • CVKD $32.00
  • STAI N/A
  • AVG Volume (30 Days)
  • CVKD 35.8K
  • STAI 472.8K
  • Earning Date
  • CVKD 08-06-2025
  • STAI 01-01-0001
  • Dividend Yield
  • CVKD N/A
  • STAI N/A
  • EPS Growth
  • CVKD N/A
  • STAI N/A
  • EPS
  • CVKD N/A
  • STAI N/A
  • Revenue
  • CVKD N/A
  • STAI $542,166.00
  • Revenue This Year
  • CVKD N/A
  • STAI N/A
  • Revenue Next Year
  • CVKD N/A
  • STAI N/A
  • P/E Ratio
  • CVKD N/A
  • STAI N/A
  • Revenue Growth
  • CVKD N/A
  • STAI N/A
  • 52 Week Low
  • CVKD $5.70
  • STAI $0.62
  • 52 Week High
  • CVKD $22.90
  • STAI $9.07
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 49.98
  • STAI N/A
  • Support Level
  • CVKD $11.00
  • STAI N/A
  • Resistance Level
  • CVKD $13.56
  • STAI N/A
  • Average True Range (ATR)
  • CVKD 1.15
  • STAI 0.00
  • MACD
  • CVKD 0.25
  • STAI 0.00
  • Stochastic Oscillator
  • CVKD 80.97
  • STAI 0.00

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About STAI ScanTech AI Systems Inc. Common stock

ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.

Share on Social Networks: